Is Rocket Pharmaceuticals (RCKT) One of the Best NASDAQ Stocks Under $5 to Buy Now?

Group 1 - Rocket Pharmaceuticals Inc. is recognized as one of the best NASDAQ stocks under $5, with the recent FDA acceptance of the resubmission of the Biologics License Application for KRESLADI [1][2] - KRESLADI is an investigational gene therapy aimed at treating severe Leukocyte Adhesion Deficiency-I, a rare genetic immune disorder, supported by positive clinical data from a global Phase 1/2 study [2][3] - The Phase 1/2 study reported a 100% overall survival rate at 12 months post-infusion, with all primary and secondary endpoints met, and no serious treatment-related adverse events [3] Group 2 - Rocket Pharmaceuticals operates as a late-stage biotechnology company focused on developing gene therapies for rare and devastating diseases in the US [4]